Controversy in heart failure management: Digoxin use in the elderly.
Chun
Jeremy
J
UCLA School of Medicine, Multicampus Program in Geriatrics and Gerontology, Los Angeles, CA, USA.
Chodosh
Joshua
J
D017677:Age Distribution; D000367:Age Factors; D000368:Aged; D000369:Aged, 80 and over; D002316:Cardiotonic Agents / Q000494:pharmacology / Q000627:therapeutic use*; D003971:Diastole; D004077:Digoxin / Q000494:pharmacology / Q000627:therapeutic use*; D004334:Drug Administration Schedule; D016903:Drug Monitoring; D019317:Evidence-Based Medicine; D005260:Female; D005853:Geriatrics / Q000379:methods* / Q000592:standards / Q000706:statistics & numerical data; D006333:Heart Failure / Q000175:diagnosis / Q000188:drug therapy* / Q000453:epidemiology; D006801:Humans; D008297:Male; D009735:Nursing Homes; D018579:Patient Selection; D017410:Practice Guidelines as Topic; D010818:Practice Patterns, Physicians' / Q000592:standards / Q000706:statistics & numerical data; D012449:Safety; D012727:Sex Characteristics; D013599:Systole; D016896:Treatment Outcome; D014481:United States / Q000453:epidemiology
D002316:Cardiotonic Agents; D004077:Digoxin